Source: Biomedicine & Pharmacotherapy. Unidades: HU, FM
Subjects: SÍNDROME CORONARIANA AGUDA, INFARTO DO MIOCÁRDIO, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEOCÁDIO, Paola Caroline Lacerda et al. Low serum levels of CCL2 are associated with worse prognosis in patients with Acute Coronary Syndrome: 2-year survival analysis. Biomedicine & Pharmacotherapy, v. 109, p. 1411-1416, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2018.10.087. Acesso em: 16 nov. 2024.APA
Leocádio, P. C. L., Menta, P. L. dos R., Dias, M. T. S., Fraga, J. R., Goulart, A. C., Santos, I. de S., et al. (2019). Low serum levels of CCL2 are associated with worse prognosis in patients with Acute Coronary Syndrome: 2-year survival analysis. Biomedicine & Pharmacotherapy, 109, 1411-1416. doi:10.1016/j.biopha.2018.10.087NLM
Leocádio PCL, Menta PL dos R, Dias MTS, Fraga JR, Goulart AC, Santos I de S, Lotufo PA, Benseñor IM, Alvarez-Leite JI. Low serum levels of CCL2 are associated with worse prognosis in patients with Acute Coronary Syndrome: 2-year survival analysis [Internet]. Biomedicine & Pharmacotherapy. 2019 ; 109 1411-1416.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.biopha.2018.10.087Vancouver
Leocádio PCL, Menta PL dos R, Dias MTS, Fraga JR, Goulart AC, Santos I de S, Lotufo PA, Benseñor IM, Alvarez-Leite JI. Low serum levels of CCL2 are associated with worse prognosis in patients with Acute Coronary Syndrome: 2-year survival analysis [Internet]. Biomedicine & Pharmacotherapy. 2019 ; 109 1411-1416.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.biopha.2018.10.087
